CrossRef High-fat diet, gut dysbiosis, and oxidative stress: A synergistic triangle in metabolic dysfunction-associated steatotic liver disease pathogenesis Zi-Rui Zhang, Ling She, Yi-Rong Cao, Yuan-Wen Chen World Journal of Hepatology .2026;[Epub] CrossRef Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease Allen Anthony Larao, Silvia Palmisano, Deborah Bonazza, Discipio Marina, Marica Meroni, Anna Ludovica Fracanzani, Lory S Croc, Claudio Tiribelli, Paola Dongiovanni, Natalia Rosso, Pablo Giraudi Annals of Hepatology .2026
The only FDA-approved GHRH analogue in a related area is Tesamorelin (Egrifta, 2010, for HIV-associated lipodystrophy)
A Medical Overview and Guide to Prescription Access Monday, 02 March 2026 11:35 AM Company Update AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 receptor agonists
The solution: Eat smaller, more frequent meals to manage nausea
When the FDA investigates suicide reports, Novo Nordisk cooperates fully